miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor–positive breast cancer

Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer

(2016) Lufeng Zheng et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes

(2016) Claudia Berrondo et al.   PLoS One

miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion

(2015) Hong Zhang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ

(2015) Jian Yuan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4

(2015) Aamir Ahmad et al.   BMC CANCER

The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1

(2015) Lufeng Zheng et al.   BREAST CANCER RESEARCH AND TREATMENT

MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy

(2015) Xinfeng Yu et al.   Molecular Cancer

Erratum: MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells

(2015) J Cui et al.   ONCOGENE

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*

(2015) Mingrong Lü et al.   Scientific Reports

MiR-125a-3p Regulates Glioma Apoptosis and Invasion by Regulating Nrg1

(2015) Feng Yin et al.   PLoS One

HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer

(2014) Manoj M. Pillai et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer

(2014) Aoife Ward et al.   JOURNAL OF PATHOLOGY

miRNA Dysregulation in Breast Cancer

(2013) L. Mulrane et al.   CANCER RESEARCH

microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn

(2013) L. Ninio-Many et al.   JOURNAL OF CELL SCIENCE

Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells

(2012) J. Cui et al.   CANCER RESEARCH

Clinical Applications for microRNAs in Cancer

(2012) S P Nana-Sinkam et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

miRNAs and estrogen action

(2012) Carolyn M. Klinge   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer

(2011) D. McCartan et al.   CANCER RESEARCH

MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab

(2011) N. Nishida et al.   CLINICAL CANCER RESEARCH

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

(2010) Lili Jiang et al.   BMC CANCER

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells

(2010) Józefa Węsierska-Gądek et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration

(2010) Vipin Yadav et al.   MOLECULAR CARCINOGENESIS

MicroRNA-125a represses cell growth by targeting HuR in breast cancer

(2010) Xun Guo et al.   RNA Biology

Epidermal growth factor receptor-regulated miR-125a-5p - a metastatic inhibitor of lung cancer

(2009) Guofu Wang et al.   FEBS Journal

Germline mutation of microRNA-125a is associated with breast cancer

(2009) W Li et al.   JOURNAL OF MEDICAL GENETICS

Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization

(2008) M. A. Qadir et al.   BREAST CANCER RESEARCH AND TREATMENT

Cyclin-Dependent Kinase-3-Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation

(2008) Y.-Y. Cho et al.   CANCER RESEARCH

MicroRNA Expression Profiles in Serous Ovarian Carcinoma

(2008) E. J. Nam et al.   CLINICAL CANCER RESEARCH